Randomized Controlled Trial
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jul 14, 2015; 21(26): 8184-8194
Published online Jul 14, 2015. doi: 10.3748/wjg.v21.i26.8184
Table 1 Inclusion and Exclusion criteria
Inclusion criteria
All patients ≥ 50 yr of age who reported for a screening or surveillance colonoscopy and had a history of removed adenomas were included in the study.
Exclusion criteria
Patients who were unable to sign the informed consent form
Patients who had undergone previous (partial) resection of the large bowel, except for appendectomy
Patients with known or pre-existing colorectal carcinoma
Patients with chronic inflammatory bowel disease
Patients with known FAP or HNPCC syndromes in the family
Patients with a Quick score < 50%, pTT > 50 s, or thrombocytes < 50000/μL who had received no specific measures for the improvement of their coagulation (FFP, TK) before the examination
Patients suffering from a severe underlying disease (ASA > II°)
Patients who were determined to have a cleanliness score of 3 on the Boston Bowel Preparation Scale for the proximal portion of the colon during the examination
Patients in whom a complete colonoscopy could not be performed in the first or second step of the investigation
Patients in whom the first step of the investigation took ≥ 45 min